Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rébillard A[au]:

The Oxygen Paradox, the French Paradox, and age-related diseases. Davies JMS et al. Geroscience. (2017)

A Review of Physical Activity and Circulating miRNA Expression: Implications in Cancer Risk and Progression. Dufresne S et al. Cancer Epidemiol Biomarkers Prev. (2018)

How should we define STAT3 as an oncogene and as a potential target for therapy? Sellier H et al. JAKSTAT. (2013)

Search results

Items: 35

1.

[Patients with prostate cancer treated by androgen deprivation therapy: Impact of adapted physical activity].

Veni T, Leroy V, Pradère B, Rébillard A, Mathieu R.

Prog Urol. 2019 Nov;29(15):912-916. doi: 10.1016/j.purol.2019.09.005. Epub 2019 Oct 18. French.

PMID:
31635895
2.

The Oxygen Paradox, the French Paradox, and age-related diseases.

Davies JMS, Cillard J, Friguet B, Cadenas E, Cadet J, Cayce R, Fishmann A, Liao D, Bulteau AL, Derbré F, Rébillard A, Burstein S, Hirsch E, Kloner RA, Jakowec M, Petzinger G, Sauce D, Sennlaub F, Limon I, Ursini F, Maiorino M, Economides C, Pike CJ, Cohen P, Salvayre AN, Halliday MR, Lundquist AJ, Jakowec NA, Mechta-Grigoriou F, Mericskay M, Mariani J, Li Z, Huang D, Grant E, Forman HJ, Finch CE, Sun PY, Pomatto LCD, Agbulut O, Warburton D, Neri C, Rouis M, Cillard P, Capeau J, Rosenbaum J, Davies KJA.

Geroscience. 2017 Dec;39(5-6):499-550. doi: 10.1007/s11357-017-0002-y. Epub 2017 Dec 21. Review.

3.

A Review of Physical Activity and Circulating miRNA Expression: Implications in Cancer Risk and Progression.

Dufresne S, Rébillard A, Muti P, Friedenreich CM, Brenner DR.

Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):11-24. doi: 10.1158/1055-9965.EPI-16-0969. Epub 2017 Nov 15. Review.

4.

The Practice of Physical Activity in the Setting of Lower-Extremities Sarcomas: A First Step toward Clinical Optimization.

Assi M, Ropars M, Rébillard A.

Front Physiol. 2017 Oct 25;8:833. doi: 10.3389/fphys.2017.00833. eCollection 2017.

5.

Interleukin-6, C/EBP-β and PPAR-γ expression correlates with intramuscular liposarcoma growth in mice: The impact of voluntary physical activity levels.

Assi M, Kenawi M, Ropars M, Rébillard A.

Biochem Biophys Res Commun. 2017 Aug 26;490(3):1026-1032. doi: 10.1016/j.bbrc.2017.06.158. Epub 2017 Jun 28.

6.

Maintaining a regular physical activity aggravates intramuscular tumor growth in an orthotopic liposarcoma model.

Assi M, Derbré F, Lefeuvre-Orfila L, Saligaut D, Stock N, Ropars M, Rébillard A.

Am J Cancer Res. 2017 May 1;7(5):1037-1053. eCollection 2017.

7.

The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts.

Assi M, Rébillard A.

Oxid Med Cell Longev. 2016;2016:9579868. doi: 10.1155/2016/9579868. Epub 2016 Aug 24. Review.

8.

Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice.

Assi M, Derbré F, Lefeuvre-Orfila L, Rébillard A.

Free Radic Biol Med. 2016 Feb;91:204-14. doi: 10.1016/j.freeradbiomed.2015.12.019. Epub 2015 Dec 18.

9.

Acute Electrical Pulse Stimulation and Hyperglycemia Regulates RCAN1-4 in C2C12 myotubes through Oxidative Stress.

Emrani Bidi R, Rebillard A, Saligaut D, Delamarche A, Davies KJ, Cillard J.

Free Radic Biol Med. 2014 Oct;75 Suppl 1:S29. doi: 10.1016/j.freeradbiomed.2014.10.757. Epub 2014 Dec 10.

PMID:
26461328
10.

Antioxidants and muscle atrophy in colon cancer: beneficial or deleterious effects?

Derbré F, Assi M, Lefeuvre-Orfila L, Vincent S, Chevalier M, Gueritat J, Salaun E, Rebillard A.

Free Radic Biol Med. 2014 Oct;75 Suppl 1:S22. doi: 10.1016/j.freeradbiomed.2014.10.735. Epub 2014 Dec 10.

PMID:
26461307
11.

The calcineurin antagonist RCAN1-4 is induced by exhaustive exercise in rat skeletal muscle.

Emrani R, Rébillard A, Lefeuvre L, Gratas-Delamarche A, Davies KJ, Cillard J.

Free Radic Biol Med. 2015 Oct;87:290-9. doi: 10.1016/j.freeradbiomed.2015.06.023. Epub 2015 Jun 26.

12.

Silver-zeolite combined to polyphenol-rich extracts of Ascophyllum nodosum: potential active role in prevention of periodontal diseases.

Tamanai-Shacoori Z, Chandad F, Rébillard A, Cillard J, Bonnaure-Mallet M.

PLoS One. 2014 Oct 1;9(10):e105475. doi: 10.1371/journal.pone.0105475. eCollection 2014.

13.

Exercise training combined with antioxidant supplementation prevents the antiproliferative activity of their single treatment in prostate cancer through inhibition of redox adaptation.

Gueritat J, Lefeuvre-Orfila L, Vincent S, Cretual A, Ravanat JL, Gratas-Delamarche A, Rannou-Bekono F, Rebillard A.

Free Radic Biol Med. 2014 Dec;77:95-105. doi: 10.1016/j.freeradbiomed.2014.09.009. Epub 2014 Sep 16.

PMID:
25236740
14.

Superoxide production pathways in aortas of diabetic rats: beneficial effects of insulin therapy and endurance training.

Malardé L, Rebillard A, Le Douairon-Lahaye S, Vincent S, Zguira MS, Lemoine-Morel S, Gratas-Delamarche A, Groussard C.

Mol Cell Biochem. 2014 Apr;389(1-2):113-8. doi: 10.1007/s11010-013-1932-z. Epub 2013 Dec 29.

PMID:
24374791
15.

How should we define STAT3 as an oncogene and as a potential target for therapy?

Sellier H, Rébillard A, Guette C, Barré B, Coqueret O.

JAKSTAT. 2013 Jul 1;2(3):e24716. doi: 10.4161/jkst.24716. Epub 2013 Apr 16. Review.

16.

Sphingolipids and response to chemotherapy.

Dimanche-Boitrel MT, Rebillard A.

Handb Exp Pharmacol. 2013;(216):73-91. doi: 10.1007/978-3-7091-1511-4_4. Review.

PMID:
23563652
17.

Prostate cancer and physical activity: adaptive response to oxidative stress.

Rebillard A, Lefeuvre-Orfila L, Gueritat J, Cillard J.

Free Radic Biol Med. 2013 Jul;60:115-24. doi: 10.1016/j.freeradbiomed.2013.02.009. Epub 2013 Feb 24. Review.

PMID:
23462616
18.

Ceramide in chemotherapy of tumors.

Dimanche-Boitrel MT, Rebillard A, Gulbins E.

Recent Pat Anticancer Drug Discov. 2011 Sep;6(3):284-93. doi: 10.2174/157489211796957838. Review.

PMID:
21762073
19.

Effects of exercise training combined with insulin treatment on cardiac NOS1 signaling pathways in type 1 diabetic rats.

Le Douairon Lahaye S, Rebillard A, Zguira MS, Malardé L, Saïag B, Gratas-Delamarche A, Carré F, Bekono FR.

Mol Cell Biochem. 2011 Jan;347(1-2):53-62. doi: 10.1007/s11010-010-0611-6. Epub 2010 Oct 9.

PMID:
20936328
20.

Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells.

Rebillard A, Jouan-Lanhouet S, Jouan E, Legembre P, Pizon M, Sergent O, Gilot D, Tekpli X, Lagadic-Gossmann D, Dimanche-Boitrel MT.

Eur J Cancer. 2010 May;46(8):1445-55. doi: 10.1016/j.ejca.2010.01.034. Epub 2010 Mar 4.

PMID:
20202822
21.

NPC1 repression contributes to lipid accumulation in human macrophages exposed to environmental aryl hydrocarbons.

Podechard N, Le Ferrec E, Rebillard A, Fardel O, Lecureur V.

Cardiovasc Res. 2009 May 1;82(2):361-70. doi: 10.1093/cvr/cvp007. Epub 2009 Jan 8.

PMID:
19131362
22.

Cisplatin cytotoxicity: DNA and plasma membrane targets.

Rebillard A, Lagadic-Gossmann D, Dimanche-Boitrel MT.

Curr Med Chem. 2008;15(26):2656-63. Review.

PMID:
18991628
23.

Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage.

Rebillard A, Rioux-Leclercq N, Muller C, Bellaud P, Jouan F, Meurette O, Jouan E, Vernhet L, Le Quément C, Carpinteiro A, Schenck M, Lagadic-Gossmann D, Gulbins E, Dimanche-Boitrel MT.

Oncogene. 2008 Nov 20;27(51):6590-5. doi: 10.1038/onc.2008.257. Epub 2008 Aug 4.

PMID:
18679423
24.

Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway.

Bénéteau M, Pizon M, Chaigne-Delalande B, Daburon S, Moreau P, De Giorgi F, Ichas F, Rebillard A, Dimanche-Boitrel MT, Taupin JL, Moreau JF, Legembre P.

Mol Cancer Res. 2008 Apr;6(4):604-13. doi: 10.1158/1541-7786.MCR-07-0331.

25.

Ethanol induces oxidative stress in primary rat hepatocytes through the early involvement of lipid raft clustering.

Nourissat P, Travert M, Chevanne M, Tekpli X, Rebillard A, Le Moigne-Müller G, Rissel M, Cillard J, Dimanche-Boitrel MT, Lagadic-Gossmann D, Sergent O.

Hepatology. 2008 Jan;47(1):59-70.

PMID:
18038449
26.

Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells.

Rebillard A, Tekpli X, Meurette O, Sergent O, LeMoigne-Muller G, Vernhet L, Gorria M, Chevanne M, Christmann M, Kaina B, Counillon L, Gulbins E, Lagadic-Gossmann D, Dimanche-Boitrel MT.

Cancer Res. 2007 Aug 15;67(16):7865-74.

27.

Cytotoxicity of TRAIL/anticancer drug combinations in human normal cells.

Meurette O, Fontaine A, Rebillard A, Le Moigne G, Lamy T, Lagadic-Gossmann D, Dimanche-Boitrel MT.

Ann N Y Acad Sci. 2006 Dec;1090:209-16.

PMID:
17384264
28.

TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions.

Meurette O, Rebillard A, Huc L, Le Moigne G, Merino D, Micheau O, Lagadic-Gossmann D, Dimanche-Boitrel MT.

Cancer Res. 2007 Jan 1;67(1):218-26.

29.

Protective effect of monosialoganglioside GM1 against chemically induced apoptosis through targeting of mitochondrial function and iron transport.

Gorria M, Huc L, Sergent O, Rebillard A, Gaboriau F, Dimanche-Boitrel MT, Lagadic-Gossmann D.

Biochem Pharmacol. 2006 Nov 15;72(10):1343-53. Epub 2006 Sep 7.

PMID:
16962073
30.

TRAIL (TNF-related apoptosis-inducing ligand) induces necrosis-like cell death in tumor cells at acidic extracellular pH.

Meurette O, Huc L, Rebillard A, Le Moigne G, Lagadic-Gossmann D, Dimanche-Boitrel MT.

Ann N Y Acad Sci. 2005 Nov;1056:379-87.

PMID:
16387703
31.

Role of early plasma membrane events in chemotherapy-induced cell death.

Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S.

Drug Resist Updat. 2005 Feb-Apr;8(1-2):5-14. Review.

PMID:
15939338
32.

Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.

Meurette O, Lefeuvre-Orfila L, Rebillard A, Lagadic-Gossmann D, Dimanche-Boitrel MT.

Clin Cancer Res. 2005 Apr 15;11(8):3075-83.

34.

[CD44 expression: a new prognostic factor in neuroblastoma].

Combaret V, Lasset C, Bouvier R, Frappaz D, Thiesse P, Rebillard AC, Philip T, Favrot MC.

Bull Cancer. 1995 Jan;82(2):131-6. French.

PMID:
10846530
35.

Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors.

Combaret V, Lasset C, Frappaz D, Bouvier R, Thiesse P, Rebillard AC, Philip T, Favrot MC.

Eur J Cancer. 1995;31A(4):545-9.

PMID:
7576964

Supplemental Content

Loading ...
Support Center